Guest Contributor

Bridging Canada's biotherapeutic gap: A call for strategic investment in translational research

Guest Contributor
December 18, 2024

For Canada to continue to grow and benefit from life science innovations, we need to push for greater and sustained investment in translational research, writes Stéphanie Michaud, president CEO of BioCanRx.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics
Organizations: BioCanRX
People: Dr. Stéphanie Michaud
Topics: importance of supporting translational research

Other News

AI holds the key to reversing Canada’s productivity crisis but an AI-focused industrial strategy is required

Community-focused health innovation is thriving in developing countries, where necessity is the mother of invention

The Short Report: December 11, 2024

Citizen-centered innovation is the way for Canada to rebalance its innovation ecosystem






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.